This cascade could be modulated through well-timed mTORC1 inhibition as suggested by the ameliorated SNP expression, increased SD length, and reduction of glomerulosclerosis in rapamycin-treated Ercc1-deficient animals. The gene discussed is ERCC1; the disease is glomerulosclerosis.